A carregar...
The biology behind PI3K inhibition in chronic lymphocytic leukaemia
Phosphoinositide 3′-kinase (PI3K) is a key component of both chronic active and tonic B-cell receptor-signalling pathways. As such, PI3K inhibitors have emerged as promising therapeutic agents for diverse lymphoid malignancies, particularly chronic lymphocytic leukaemia. Multiple in vitro experiment...
Na minha lista:
| Publicado no: | Ther Adv Hematol |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4298491/ https://ncbi.nlm.nih.gov/pubmed/25642313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620714561581 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|